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TGF-β signaling is a cellular pathway that functions in most cells and has been shown to
play a role in multiple processes, such as the immune response, cell differentiation and pro-
liferation. Recent evidence suggests a possible interaction between TGF-β signaling and
the molecular circadian oscillator. The current study aims to characterize this interaction in
the zebrafish at the molecular and behavioral levels, taking advantage of the early develop-
ment of a functional circadian clock and the availability of light-entrainable clock-containing
cell lines.
Results
Smad3a, a TGF-β signaling-related gene, exhibited a circadian expression pattern through-
out the brain of zebrafish larvae. Both pharmacological inhibition and indirect activation of
TGF-β signaling in zebrafish Pac-2 cells caused a concentration dependent disruption of
rhythmic promoter activity of the core clock gene Per1b. Inhibition of TGF-β signaling in
intact zebrafish larvae caused a phase delay in the rhythmic expression of Per1b mRNA.
TGF-β inhibition also reversibly disrupted, phase delayed and increased the period of circa-
dian rhythms of locomotor activity in zebrafish larvae.
Conclusions
The current research provides evidence for an interaction between the TGF-β signaling
pathway and the circadian clock system at the molecular and behavioral levels, and points
to the importance of TGF-β signaling for normal circadian clock function. Future examination
of this interaction should contribute to a better understanding of its underlying mechanisms
and its influence on a variety of cellular processes including the cell cycle, with possible
implications for cancer development and progression.
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Introduction
As a result of the earth’s rotation around its axis, the majority of organisms are exposed to
rhythmic daily changes in their environment, including illumination, ambient temperature
and food availability. Organisms adapt to these changes by exhibiting a wide variety of physio-
logical and behavioral daily rhythms which are driven by an intrinsic timing mechanism
known as the circadian clock. The underlying mechanism of the circadian clock relies on a
network of positive and negative transcriptional-translational feedback loops, which constitute
a molecular oscillator that drives rhythmic expression of clock components with a period of
approximately 24 hr. In vertebrates, positive elements of this feedback loop include the pro-
teins Clock and Bmal1, which heterodimerize and act as transcription factors for genes con-
taining E-box enhancer elements, including the genes encoding negative elements of the
feedback loop, namely Per and Cry. After being translated, Per and Cry proteins heterodimer-
ize, enter the nucleus and suppress the activity of Clock:Bmal1, thus downregulating their own
transcription. A new cycle begins when Clock:Bmal1 repression is eliminated via the degrada-
tion of Per and Cry. This core molecular mechanism affects other cellular functions by direct-
ing the circadian expression pattern of a variety of genes, collectively called clock-controlled
genes (CCGs), which in turn regulate downstream processes. Some of these CCGs, for example
Dec1 and Rev-erbα, feedback on the core clock mechanism itself [1–4].
The circadian clock influences nearly all aspects of an organism’s physiology and behavior,
such as sleep-wake cycles, changes in body temperature, hormone secretion and metabolism
[5,6]. Disruption of the circadian clock system and dis-synchronization of its derived rhythms
have been suggested to increase the risk for several diseases and syndromes, including tumori-
genesis and tumor progression [7,8], metabolic syndromes and obesity [9], as well as Alzhei-
mer’s disease [10,11]. However, although the molecular mechanism of the circadian clock is
well characterized and the influence of the clock on multiple physiological processes has been
well documented, the underlying mechanisms linking clock disruption with these disorders
are not fully understood.
TGF-β is a widely expressed and secreted protein that has been shown to play a key role in
multiple processes, including the immune response, cell differentiation and proliferation [12],
and has been particularly well studied in the context of cancer biology [13]. The binding of
TGF-β to one of its receptors, ALK4, ALK5 or ALK7, leads to the phosphorylation of Smad2
or Smad3, their association with Smad4, and their translocation into the nucleus. In the
nucleus, the Smad2/3-Smad4 complex act as a transcription factor, in association with various
co-activators and co-repressors to activate or repress the transcription of many genes and cel-
lular processes [14–17]. TGF-β is associated with elaborate negative feedback mechanisms.
These mechanisms include inhibitory SMADs (like SMAD7) and co-repressors (such as
TGIF1 [14,18]). An effect of TGF-β signaling on the circadian clock was initially proposed
based on evidence that activation of ALK receptors by TGF-β leads to the induction of Dec1
activity and consequent resetting of the molecular oscillator [19]. This evidence was later rein-
forced by studies revealing that TGF-β2 inhibits the expression of several clock genes [20].
Moreover, it was shown that Smad3 mRNA exhibits rhythmic expression in human cell lines
and the mouse liver [21], and that TGF-β and phosphorylated Smad3 (pSmad3) proteins
exhibit a circadian expression pattern in the hypothalamic superchiasmatic nucleus, the site of
the master clock in mammals [22]. Together, these recent findings suggest a bi-directional
interaction between the circadian clock and TGF-β signaling. Further examination of this
interaction should shed light on important processes known to be regulated by both systems,
including cell cycle, cancer development and progression, as well as other physiological
processes.
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Here, we have used the zebrafish as a model to characterize in more detail the functional
links between TGF-β signaling and the circadian clock. We demonstrate that a bidirectional
interaction between the clock and TGF-β signaling pathways exists at both the molecular and
behavioral levels. Importantly, we reveal that TGF-β signaling is essential for normal circadian
clock function in this species.
Results
1. Circadian clock-regulated components of the TGF-β signaling pathway
1.1 TGF-β signaling genes exhibit clock-dependent circadian expression pattern in the
zebrafish. To explore the influence of the circadian clock on TGF-β signaling, we first tested
whether TGF-β signaling-related genes exhibit a circadian expression pattern in the zebrafish.
First, we analyzed transcriptome data from a previous microarray experiment performed
using whole zebrafish larvae, which revealed 2,847 genes showing a circadian expression pat-
tern [23]. Examination of this data revealed that TGF-β signaling genes Smad3a, Tgif1 and
Smad7 exhibit rhythmic expression in zebrafish larvae. Smad3a displays high levels at the end
of the night and at the beginning of the light period, peaking at CT4, and then low levels at the
beginning of the night. Instead, Smad7 and Tgif1 display high levels at the beginning of the
night, with a peak at CT12, and low levels at the beginning of the light period. The expression
of other TGF-β related genes, such as tgfb1a, tgfb2, tgfb3 and smad3b did not show significant
circadian rhythmicity.
We next tested whether these genes also exhibit a circadian expression pattern in adult zeb-
rafish. We initially analyzed existing microarray data obtained from adult zebrafish brains,
which demonstrated 714 genes that exhibit a circadian expression pattern [24]. Examination
of this data revealed that while Smad3a exhibits a circadian expression pattern in the adult zeb-
rafish brain, peaking at CT4, Smad7, Tgif1 and other TGF-β related genes do not exhibit such
oscillations. We then examined RNAseq data obtained specifically from the pineal gland of
adult zebrafish, which is considered to play a key role in coordinating circadian rhythmicity in
the entire organism [4,25]. Amongst 308 genes which exhibited a circadian expression pattern
in the zebrafish pineal gland [23,24], the TGF-β signaling genes Smad3a, Tgif1 and Smad7
exhibit a rhythmic expression, peaking at CT2, CT10 and CT10, respectively (Fig 1). The
extent to which the circadian rhythmicity of each gene corresponded to a period of 24 hr was
quantified using a ’g-factor’ value. To calculate the ’g-factor’, the gene expression data, which
is a time dependent signal, is converted into a frequency dependent signal using the Fast Fou-
rier Transform (FFT). The ratio between the power of frequency that corresponds to the 24 hr
period to the sum of powers of all frequencies is called the ’g-factor’, and its values range
between zero and one [26,27]. The ’g-factor’ of the three TGF-β signaling genes was similar to
that of known clock-controlled genes, such as aanat2. Importantly, as evident in the ‘g-factor’
values, circadian rhythmicity in the expression of these three genes was diminished in the
transgenic zebrafish line Tg(aanat2:EGFP-ΔCLK) which expresses a dominant-negative form
of CLOCK in the melatonin-producing photoreceptor cells of the pineal gland, thereby dis-
rupting circadian-clock function [28]. This observation suggests that rhythmic expression of
these TGF-β signaling genes is driven, directly or indirectly, by the core molecular clock in the
pineal.
1.2 Smad3a mRNA shows a circadian clock-controlled expression in zebrafish larvae
heads. Next, we investigated the spatio-temporal expression pattern of Smad3a in the whole
organism, using whole mount in situ hybridization (ISH). Zebrafish larvae were exposed to 12
hr:12 hr light/dark (LD) cycles for 5 days, and on the night of the 5th day of development, half
were transferred to DD. During the 6th and 7th days of development the larvae were collected
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at 4 hour intervals and mRNA was detected and semi-quantified by a whole mount ISH proto-
col (n = 15/group). This analysis indicated that Smad3a mRNA exhibits a circadian expression
pattern in the zebrafish larva head (Fig 2). The observed levels of Smad3a mRNA expression
was significantly affected by sampling time (p<0.001, two-way ANOVA), showing higher
expression levels during late night-time and daytime than early night-time. This pattern per-
sisted in DD, indicating that it is regulated by an endogenous circadian clock. Smad3a mRNA
expression was also significantly affected by lighting conditions (p<0.001, two-way ANOVA),
with a significant interaction between sampling time and light conditions (p<0.001, two-way
ANOVA). The rhythmic expression pattern of Smad3a under DD in the zebrafish larva head
was similar to that found in our previous transcriptome analyses (See section 1.1). In contrast
to Smad3a, another zebrafish paralog of Smad3, Smad3b, did not show any time- or light-
dependent expression pattern (S1 Fig), corroborating the results of previous transcriptome
analyses (See section 1.1). These results sustain the notion that Smad3a exhibits a circadian
expression pattern regulated by the circadian clock in the whole larva head.
2. TGF-β signaling pathway affects the circadian clock
2.1 Disruption of TGF-β signaling interferes with the molecular circadian clock in zeb-
rafish PAC-2 cells. Previous studies have demonstrated that TGF-β influences the expression
of several clock genes in human cell lines and mice liver [21]. In order to more precisely exam-
ine the influence of TGF-β signaling on peripheral circadian clock function, we tested the
effect of pharmacologically blocking TGF-β signaling on the molecular circadian oscillator in
zebrafish PAC-2 cells stably transfected with a clock gene promotor-reporter construct, Tg
(-3.1)per1b::luc [29].
Cells were exposed to 3 LD cycles for entrainment. Then, 30 minutes before lights on a
selective ATP-competitive inhibitor of the TGF-β receptor ALK5, LY-364947, was added to
the cell culture medium at different concentrations (1, 5, 10, 20 μM). This inhibitor was previ-
ously shown to inhibit TGF-β-Smad3 mediated signaling in zebrafish larvae [30]. Cells were
maintained in LD for an additional 2 days and then transferred to DD for 3 additional days.
Luciferase activity was monitored and compared with that of vehicle treated control cells
(n = 4/group). The addition of TGF- β inhibitor LY-364947 altered the clock controlled rhyth-
mic activity of the per1b promotor in a dose-dependent manner (Fig 3).
Treatment with TGF-β inhibitor LY-364947 led to a significant lengthening of the period of
Per1b promotor activity in all inhibitor concentrations (25±0, 26.62±0.12, 30.5±0.2, 27±0.0 hr
for 1, 5, 10 and 20 μM, respectively, compared to 24.37±0.12 for the DMSO treated control,
p<0.001, one-way ANOVA, p<0.05, Tukey’s post-hoc). This led to a significant dose-depen-
dent phase delay in higher (10 and 20 μM) inhibitor concentrations (the time of the first peak
after the cells were transferred to DD was at CT 3.95±0.74, 7.08±0.46, 12.08±1.4 and 15.4±0.67
for 1, 5, 10 and 20 μM, respectively, compared to CT 3.2±0.24 for the DMSO treated control,
p<0.001, one-way ANOVA, p<0.05, Tukey’s post-hoc). The treatment also led to a reduction
Fig 1. Clock-dependent circadian expression pattern of Smad3a, Smad7, and Tgif1 in the adult zebrafish pineal gland. Data mining of a
previous RNA-sequencing experiment reveals that the TGF-β signaling genes Smad3a (top left), Smad7 (top right) and Tgif1 (mid left) exhibit a
circadian expression pattern in the zebrafish pineal gland under constant darkness (DD), which is diminished in transgenic fish with a disrupted
pineal circadian clock, Tg(aanat2: EGFP-ΔCLK), similarly to the known clock-controlled gene, aanat2 (mid right). Grey bars represent subjective
day and black bars represent subjective night. CT0 corresponds to “subjective lights on”, CT12 to “subjective lights-off”. Bottom: a comparison
between the g-factor values of different TGF-β signaling genes in both control and transgenic fish. In control fish, Smad3a, Smad7 and Tgif1
exhibit rhythmic expression patterns with a high g-factor value, similar to that of aanat2, indicating that they indeed exhibit a circadian
expression pattern. In ΔClock fish these genes lose their rhythmic expression pattern as indicated by significantly lower g-factor values, implying
that their circadian pattern is regulated by the core mechanism of the circadian clock. The TGF-β related genes Tfgb1a, Tgfb2,Tgfb3and Smad3b
exhibit low g-factor values in both groups, indicating they are not expressed in a circadian manner in the zebrafish pineal gland.
https://doi.org/10.1371/journal.pone.0199777.g001
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Fig 2. Smad3a mRNA shows a circadian clock-controlled expression in zebrafish larvae heads. Smad3a mRNA exhibits a circadian rhythm expression
pattern in zebrafish larvae heads, with mRNA expression significantly affected by sampling time (p<00.1, two-way ANOVA), showing higher expression levels
during late night-time and daytime than early night-time. This pattern persists in constant darkness, suggesting that it is regulated by the circadian clock. In
addition, Smad3a mRNA expression is also significantly affected by lighting conditions (p<0.001, two-way ANOVA), with a significant interaction between
sampling time and light conditions (p<0.001, two-way ANOVA) (n = 15/group). (A) Top panel: schematic representation of the experimental design. The
horizontal bars represent the lighting conditions before and during sampling; white boxes represent light and black boxes represent dark periods. Bottom
panel: whole mount ISH images for Smad3a mRNA (dorsal views) of representative specimens raised under LD cycles until and during sampling or kept
under DD during sampling. Circadian times are indicated for each sample. CT0 corresponds to “subjective lights on”, CT12 to “subjective lights-off”. White
bars represent light phases and black bars represent dark phases. (B) Left: quantification of signal intensities in the head of larvae under LD and DD. Values
represent the mean ±SE optical densities of the head signals. White bars represent subjective day and black bars represent subjective night. Right: Different
letters represent statistically different values within each photoperiodic treatment (p<0.05, one-way ANOVA, Tukey’s test). This experiment was repeated
twice resulting in a similar outcome. The represented results are of one experiment.
https://doi.org/10.1371/journal.pone.0199777.g002
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in the amplitude of rhythmic Per1b promotor activity during the first DD cycle after exposure
in all concentrations but 10μM (256.25±20.51, 234.62±22.38, 321.5±26.12, 267.33±18.78 CPS
for 1, 5, 10 and 20 μM, respectively, compared to 409±11.04 for the DMSO treated control,
p<0.001, one-way ANOVA, p<0.005, Tukey’s post-hoc). An additional experiment was per-
formed using an alternative TGF-β inhibitor of both TGF-β receptors ALK-4 and ALK-5, SB-
505124. Inhibition with SB-505124 resulted in very similar effects on amplitude and period of
per1b promotor activity, but with insignificant effects on phase (S2 Fig).
Fig 3. The molecular circadian oscillator in PAC-2 cells is significantly altered by TGF-β inhibition. Rhythmic Per1b promotor activity in the zebrafish PAC-2 cell
line was significantly altered by the addition of the TGF-β inhibitor LY-364947 in a dose-dependent manner in comparison to DMSO treated control (n = 4-12/
group). Upper panel: Luciferase bioluminescence, driven by the per1b promotor, is plotted on the y-axis and time (hours) on the x-axis. The horizontal bars represent
the lighting conditions during the measurements; white boxes represent light periods and black boxes represent dark periods. Lower panel: cells which were exposed to
LY-364947 exhibit rhythms of longer period (p<0.001, one-way ANOVA), a phase delay (p<0.001, one-way ANOVA), and a lower amplitude of expression (p<0.001,
one-way ANOVA).Different letters represent statistically different values within each parameter (p<0.05, Tukey’s test). This experiment was repeated twice, resulting
in comparable results. The represented results are of one experiment.
https://doi.org/10.1371/journal.pone.0199777.g003
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These results indicate that TGF- β signaling is essential for the rhythmic promotor activity
of a key clock gene in the PAC-2 zebrafish cell line, and therefore demonstrate the importance
of TGF-β signaling for normal function of the circadian clock mechanism.
In order to further demonstrate the influence of the TGF-β signaling system on the molecu-
lar circadian clock, we tested the effects of TGF-β signaling activation on the molecular circa-
dian oscillator in PAC-2 cells. This was done by applying the compound Alantolactone, which
disrupts Cripto-1/ActRII complexes resulting in an indirect induction of activin/Smad3 signal-
ing [31]. Cells were exposed to 3 LD cycles for entrainment. Then, at CT 23.5 Alantolactone
was added to the cell culture medium at different concentrations (1, 5 and 10 μM, n = 8/
group) and cells were transferred to DD for additional 3 days. Luciferase activity was moni-
tored and compared with that of vehicle-treated control cells.
The addition Alantolactone to the culture media disrupted the clock controlled rhythmic
activity of the per1b promotor (Fig 4). It led to a significant dose-dependent reduction in the
amplitude of rhythmic Per1b promotor activity under DD (1542.31±27.76, 968.69±16.07 CPS
for 1 and 5 μM Alantolactone respectively, compared to 2151.31±18.44 for the DMSO-treated,
during the first DD cycle after exposure, p<0.001, one-way ANOVA, p<0.001, Tukey’s post-
hoc). The period of Per1b promotor activity was reduced by the activator (24.01±0.05, 23.17
±0.05 hr for 1 and 5 μM, respectively, compared to 24.99±0.05 for the DMSO treated control,
p<0.001, one-way ANOVA, p<0.05, Tukey’s post-hoc). However, Alantolactone was not
found to effect per1b activity phase (the time of the first peak after the cells were transferred to
DD was at CT 21.42±0.07, 21.74±0.1 for 1 and 5 μM, respectively, compared to CT 21.48±0.05
for the DMSO-treated control, p<0.001, one-way ANOVA, p<0.05, Tukey’s post-hoc). At the
highest tested concentration (10μM) Alantolactone totally abolished the rhythm; amplitude,
period and phase were therefore not calculated for the 10μM Alantolactone-treated cells.
2.2 TGF-β inhibition leads to phase delay of per1b mRNA rhythms in zebrafish lar-
vae. After demonstrating that pharmacological inhibition of TGF-β influences the circadian
clock of zebrafish cell lines in vitro, we next evaluated the influence of this inhibition at the
whole organism level by testing its effect on the clock-controlled rhythmic expression pattern
of Per1b mRNA. Zebrafish larvae were kept under LD cycles for 5 days. Near the end of the
light phase of the 5th day of development, approximately 30 min before the lights were turned
on, the TGF-β inhibitor LY-364947 (20µM) or diluted DMSO alone (control) was added to the
larvae water, and larvae were transferred to DD conditions. During the 6th and 7th days of
development fish were collected at 4 hr intervals and Per1b mRNA levels were measured by
whole mount ISH (n = 15/group). Per1b mRNA expression was significantly affected by sam-
pling time (p<0.001, two-way ANOVA), and there was a significant interaction between treat-
ment and sampling time (p<0.001, two-way ANOVA). Thus, the circadian expression pattern
of Per1b mRNA was significantly altered in larvae exposed to the TGF-β inhibitor, demonstrat-
ing a phase delay of circadian expression in comparison to the control group (Fig 5). The
observed phase delay is similar to the phase delay of Per1b promotor activity rhythms in PAC-
2 cells upon exposure to the TGF-β inhibitor (Fig 3). These results indicate that TGF- β signal-
ing influences the rhythmic transcription of a core clock gene in zebrafish larvae.
2.3 TGF-β inhibition reversibly disrupts clock-controlled rhythmic locomotor activity
in zebrafish larvae. Studies of the influence of TGF-β signaling on the circadian clock have
been limited so far to its influence on the core molecular mechanism [19,20]. Therefore, we
next aimed to test whether TGF-β signaling also influences a behavioral output of the clock,
namely clock-controlled circadian rhythms of locomotor activity [4,32]. The influence of a
TGF-β inhibitor on larval locomotor activity was tested following a previously described
experimental protocol [33]. Larval clocks were entrained by exposure to 3 LD cycles and two
12 hr light:12 hr dim light cycles (LDim) and then transferred to constant dim light (DimDim).
Circadian clocks and TGF-β signaling interactions
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Locomotor activity was recorded under DimDim during the 6th-7th days of development in
the presence of the TGF- β inhibitor LY-364947 (20 µM) which was added to the larvae water
during the 5th day of development (n = 24/group). Circadian rhythms of locomotor activity
were significantly affected in larvae treated with the TGF-β inhibitor in comparison with the
DMSO treated control group (Fig 6; p<0.001, Kolmogorov-Smirnov test).
Inhibitor-treated larvae exhibited a significantly lower amplitude (1.52±0.48 and 4.15
±0.84 cm/10 min for inhibitor-treated and control larvae respectively, p<0.001, t-test),
Fig 4. The molecular circadian oscillator in PAC-2 cells is significantly altered by TGF-β induction. Rhythmic Per1b promotor activity in the zebrafish PAC-2 cell
line was significantly altered by the addition of the indirect TGF-β inducer Alantolactone to the culture media in a dose-dependent manner in comparison to DMSO-
treated control (n = 8/group). Upper panel: bioluminescence is plotted on the y-axis and time (hours) on the x-axis. The horizontal bars represent the lighting conditions
during bioluminescence measurements; white boxes represent light periods and black boxes represent dark periods. Lower panel: cells which were exposed to
Alantolactone exhibit lower amplitude (p<0.001, one-way ANOVA), a phase delay (p<0.001, one-way ANOVA), and shorter periods of rhythms (p<0.001, one-way
ANOVA). Different letters represent statistically different values within each parameter (p<0.05, Tukey’s test).
https://doi.org/10.1371/journal.pone.0199777.g004
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PLOS ONE | https://doi.org/10.1371/journal.pone.0199777 June 25, 2018 9 / 23
similar to the decrease in amplitude of per1b promotor activity following TGF-β inhibition
observed in vitro.
Light exposure has been extensively documented to have an acute effect on the locomotor
activity of zebrafish larvae, independently of regulation by the endogenous circadian clock
Fig 5. Per1b mRNA circadian expression pattern in zebrafish larvae is phase-shifted by TGF-β inhibition. Zebrafish larvae were treated with TGF-β
inhibitor LY-364947 (20 μM), and the expression pattern of Per1b was evaluated by whole mount ISH. Per1b expression was detected throughout the head
region and its circadian expression pattern was altered in the presence of the TGF-β inhibitor, exhibiting a phase delay of circadian expression in comparison
to a control group (DMSO). Per1b mRNA expression was significantly affected by sampling time (p<0.001, two-way ANOVA), and by an interaction
between treatment and sampling time (p<0.001, two-way ANOVA) (n = 15/group). (A) Schematic representation of the experimental design. The horizontal
bars represent the light conditions before and during sampling; white boxes represent light and black boxes represent dark periods. Bottom panel: whole
mount ISH signals for Per1b mRNA (dorsal views of the heads) of representative specimens. Grey bars represent subjective day and black bars represent
subjective night. Circadian times are indicated for each sample. CT0 corresponds to “subjective lights on”, CT12 to “subjective lights-off”. (B) Left:
Quantification of signal intensities in the heads of treated and control larvae. Values represent the mean ± SE optical densities of the head signals. Right:
Different letters represent statistically different values within each treatment (p<0.05, one-way ANOVA, Tukey’s test). This experiment was repeated twice,
resulting in similar outcomes. The represented results are of one experiment.
https://doi.org/10.1371/journal.pone.0199777.g005
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[27]. Therefore, we next aimed to determine whether this “masking” effect of light could over-
come the effect of the TGF-β inhibitor, and restore or prevent disruption in rhythmic locomo-
tor activity of the larvae. Larvae were entrained to 3 LD and 2 LDim cycles and locomotor
activity was monitored on the 6th-8th day of development under LDim cycles in the presence
or absence of the inhibitor (n = 24/group). Circadian rhythms of locomotor activity were sig-
nificantly altered in larvae treated with TGF-β inhibitor in comparison to the DMSO treated
control group (p<0.001, Kolmogorov-Smirnov test; Fig 7). Inhibitor-treated larvae exhibited a
significantly longer period of rhythmic locomotor activity (25.86±0.75 and 23.19+1.34 hr for
treated and control larvae, respectively, p<0.05, t-test). Consequently, inhibitor-treated larvae
displayed a delayed phase (peaking at CT11±4.4 and CT5±5.22 hr for inhibitor-treated and
control larvae, respectively, p<0.001, t-test), reminiscent of the period lengthening and phase
delay observed in the activity of Per1b promotor activity in vitro (Fig 3), and the phase delay in
Fig 6. TGF-β inhibition abolishes clock-controlled rhythmic locomotor activity in zebrafish larvae. Clock-controlled rhythmic locomotor activity of
zebrafish larvae under constant dim light was abolished after treatment with the TGF-β inhibitor LY-374947 (20µM) in comparison to a control group
(DMSO). Embryos were raised under LD for 3 days, raised under LDim in the DanioVision chamber for 2 days, the inhibitor was then applied and locomotor
activity (distance moved every 10 min) was monitored under constant Dim. The data is presented as a moving average (10 sliding points) for each group
(n = 24/group). Larvae exhibited a significant reduction in the amplitude of rhythmic locomotor activity (p<0.001, t-test, bottom right panel). The horizontal
bars represent the lighting conditions before and during the experiment. White boxes represent light, black boxes represent dark and grey boxes represent
dim light (upper panel). TGF-β inhibitor-treated larvae exhibited significantly lower g-factor values (fitness to a circadian rhythm) in comparison to control
larvae (p<0.001, Kolmogorov-Smirnov test), indicating that their locomotor activity is less circadian (bottom left panel). The median is represented for each
group (red line).
https://doi.org/10.1371/journal.pone.0199777.g006
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per1b mRNA expression in vivo (Fig 5). Treated larvae also exhibited a lower amplitude
rhythm (2.49±1.02 and 3.98±1.16 cm/10 min for inhibitor treated and controlled larvae,
respectively, p<0.05, t-test), reminiscent of the decrease in the amplitude of Per1b promotor
activity in vitro. The alteration of locomotor activity circadian rhythms, even under LDim
cycles, further reinforces the importance of TGF-β signaling for the function of the circadian
system.
Given the striking effect of pharmacological TGF-β inhibition on larval circadian locomo-
tor activity, and to rule out the possibility of an irreversible toxic effect, we examined whether
this effect could be reversed. In order to address this issue, we performed an inhibitor “wash-
out” experiment: larvae were kept under LD cycles during the first 5 days of development, and
then placed in DD during the 6th-7th days of development in the presence of TGF-β inhibitor
LY-364947 (20µM). On the morning of the 8th day of development, the inhibitor was removed
by washing. Larvae were re-entrained by two LDim cycles, and then kept under DimDim con-
ditions for an additional 24 hours, during which their locomotor activity was recorded
Fig 7. TGF-β inhibition disrupts circadian locomotor activity rhythms under light:Dim light cycles. Larval rhythmic locomotor activity under LDim was
significantly disrupted (p<0.05, t-test), but not completely abolished, after treatment with the TGF-β inhibitor LY-374947 (20µM) in comparison with the
DMSO control group. Embryos were raised under LD for 3 days, raised under LDim in the DanioVision chamber for 2 days, the inhibitor was added and
locomotor activity (distance moved every 10 min) was monitored under LDim cycles. The data is presented as a moving average (10 sliding points) for each
group (n = 24/group). The horizontal bars represent the lighting conditions before and during the experiment. White boxes represent light, black boxes
represent dark and grey boxes represent dim light (upper panel). TGF-β inhibitor treated larvae exhibited significantly lower g-factor values in comparison
with control larvae (p<0.001, Kolmogorov-Smirnov test), indicating that their locomotor activity is significantly less circadian LDim cycles. The median is
represented for each group (red line). This experiment was repeated twice, resulting in similar outcomes. The represented results are of one experiment.
https://doi.org/10.1371/journal.pone.0199777.g007
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(n = 23/group). 24 hours after removal of the inhibitor, normal circadian rhythmicity of loco-
motor activity in inhibitor-treated larvae was completely recovered (Fig 8). 24 hours following
inhibitor washout there were no significant differences in the g-factor distribution between
control and inhibitor-treated larvae (p = 0.12, Kolmogorov-Smirnov test), as well as no signifi-
cant difference in amplitude (2.37±0.31 and 2.8±0.63 cm/10 min for inhibitor-treated and con-
trol larvae, respectively, p = 0.32, t-test) period length (24.77±0.26 and 25.19±0.52 hr for
treated and control larvae, respectively, p = 0.58, t-test) or phase (CT7.5±1.07 and CT8±0.28 hr
for treated and control larvae respectively, p = 0.73, t-test). This indicates that the effect of
pharmacological TGF-β inhibition on circadian rhythms of locomotor activity is reversible.
To rule out the possibility that LY-364947 simply impairs larval mobility, we performed an
additional assay for the behavioral response to light-to-dark transitions The behavioral
response of the larvae to a sudden light transition is thought to be a locomotor behavior not
regulated by the circadian clock [34], and therefore serves as a valuable parameter to test
Fig 8. The effect of TGF-β inhibition on clock-controlled rhythmic locomotor activity in zebrafish larvae is reversible. Embryos were raised under LD for 3 days,
raised under LDim in the DanioVision chamber for 2 days, the inhibitor (20μM LY-374947) was applied for an additional 2 DimDim cycles. After washing off the
inhibitor, the larvae were entrained by 2 LDim cycles and locomotor activity (distance moved every 10 min) was monitored under constant Dim. Following removal
of the TGF-β inhibitor, normal circadian rhythmicity of locomotor activity in treated larvae was recovered. A day following inhibitor wash out there were no
significant differences in the g-factor distribution between DMSO and inhibitor treated larvae (p = 0.12, Kolmogrov-Smirnov test), as well as no significant differences
in amplitude (p = 0.32, t-test), phase (p = 0.73, t-test) or period length (p = 0.58, t-test) (bottom left panel). The data is presented as a moving average (10 sliding
points) for each group (n = 23/group). The median is represented for each group (red line). This experiment was repeated twice, resulting in similar outcomes. The
represented results are of one experiment.
https://doi.org/10.1371/journal.pone.0199777.g008
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whether the TGF-β inhibitor affects larvae’s mobility. During the early light phase of the 6th
day of development, larvae were subjected to 3 dark flashes of 10 seconds each, with 15 min-
utes of light interval between flashes, in the presence of the TGF-β inhibitor LY-364947
(20µM). Locomotor activity was recorded before, during and after the dark flashes. No statisti-
cal difference was observed between the response of inhibitor-treated and control DMSO
treated larvae (n = 24/group) to dark flashes (Fig 9; p = 0.28, t-test), indicating that LY-364947
does not impair larval mobility.
Fig 9. Locomotor activity levels in response to dark flashes is not effected by TGF-β inhibition. Larvae were kept under LD cycles.
On day 5 the inhibitor, or DMSO as control, was added on day 6. Larvae were subjected to 3 dark flashes of 10 seconds each, which are
known to induce startle response, with 15 minutes intervals of light between flashes, and their activity was recorded (upper panel). No
statistical difference was observed between the activity of control (DMSO) and the TGF-β inhibitor (LY-374947, 20μM) treated groups
during the dark flashes (p = 0.28, t-test), indicating that TGF-β inhibition does not impair larval mobility (lower panel). Each line
represents the average of three succeeding trials, which measured the average movement per second of each group of larvae, recorded
from 10 second before the flash, during the flash, and 10 second after the flash. Black and white horizontal boxes represent the light
phase and dark flashes, respectively. This experiment was repeated twice, resulting in similar outcomes. The represented results are of
one experiment.
https://doi.org/10.1371/journal.pone.0199777.g009
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Discussion
Previous studies have implied the presence of a functional link between the circadian clock
and TGF-β signaling [19–22,26,35], however, this connection has not been thoroughly charac-
terized. In the present study, by data mining of transcriptome data, and the study of zebrafish
cell-lines in vitro as well as by in vivo analysis, we demonstrate interactions between the circa-
dian clock and the TGF-β signaling pathway at the molecular and behavioral levels. Further-
more, we show that TGF-β is necessary for normal circadian clock function.
Data mining of microarray and RNAseq experiments reinforces previous studies indicating
that Smad3 expression exhibits circadian oscillations [21,22], and reveals that these oscillations
occur both in whole zebrafish larvae and adult zebrafish brains, with a similar period, peaking
at the beginning of the subjective day. Furthermore, data mining reveals that the mRNA of
two additional TGF-β related gene, Smad7 and Tgif1, also exhibit clock-controlled circadian
rhythms in the whole zebrafish embryo and in adult zebrafish pineal glands (but not in the
adult zebrafish brain), with a similar period, peaking at the middle of the dark period. The E-
box and RORE promoter enhancer elements have been demonstrated to direct circadian
rhythms of gene expression in CCGs by the core clock transcription factor components Clock:
Bmal and RevErb/ROR respectively [2,3]. Interestingly, in zebrafish the phase of rhythmic
expression directed by these two enhancer elements differs by around 12 hours, with E-
box (Clock:Bmal) driven expression peaking in the early light period while RORE (RevErb
/ROR) driven expression peaks during the early night [2]. It is therefore tempting to speculate
that the rhythms of TGF-β related gene expression may reflect core clock regulation via both
types of enhancer element.
Whole mount ISH results validate and reinforce transcriptome analysis data indicating that
Smad3a mRNA exhibits a widespread circadian expression pattern in the whole head area of
zebrafish larvae. Previous results have demonstrated that Smad3a oscillates both in central cir-
cadian clock organs, namely the mouse SCN and zebrafish pineal [22], in various cell-lines and
in vivo in the mouse liver [21]. Earlier transcriptome experiments and the current experimen-
tal results strengthen the notion that Smad3a exhibits a rhythmic circadian expression pattern
in multiple peripheral tissues, which is also affected by the photic regime. Although previous
studies in mammals have suggested that the expression of TGF-β itself is regulated by the cir-
cadian clock [22,35], our own zebrafish transcriptome analysis failed to detect a circadian
expression pattern for either Tgfb1,Tgfb2, or Tgfb3. It is therefore possible that this extra layer
of regulation of TGF-β signaling by the circadian clock in mammals may have evolved follow-
ing the divergence of the teleost lineage from other vertebrates, and therefore appears in mam-
mals but not in zebrafish. Due to the lack of appropriate antibodies, we examined the
circadian profile of zebrafish TGF-β signaling elements only at the mRNA level, and not at the
protein or active protein levels. Therefore, it remains to be tested precisely how the rhythms in
mRNA influence protein levels of Smad3, phosphorylated Smad3 and TGF-β in zebrafish.
However, given that cycling protein levels for TGF-β signaling pathway elements have been
described in the mammalian SCN [22], it seems likely that a comparable protein rhythmicity
also exists in zebrafish.
We show that pharmacological inhibition of TGF-β causes period lengthening, a conse-
quent phase delay and a decrease in amplitude of rhythmic expression of the core clock gene
Per1b in PAC-2 cells, and a phase delay in the rhythmic expression of Per1b mRNA in vivo.
Since Per1b plays a key role in the molecular mechanism of the circadian clock [1], a change in
Per1b promotor activity and mRNA expression reflects alterations in the expression of other
clock genes and indicates a general shift in the molecular mechanism of the circadian clock.
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Interestingly, pharmacological indirect activation of TGF-β signaling using Alantolactone
also disrupted the rhythmic expression of the core clock gene Per1b in PAC-2 cells, causing a
decrease in amplitude and a period shortening. Such results might indicate a significant dis-
ruption in TGF-β signaling, either decrease or increase, disrupts the activity of the molecular
circadian clock. It is important to note some of the effects observed in the indirect activation
of TGF-β experiments might be due to unknown effects of the compound Alantolactone on
other cellular pathways [31]. Importantly, it should be noted that previous evidence suggest
Alantolactone does not have any largely visible effects on non-cancerous cells [31].
The observed alternations in the period and phase of Per1b rhythmic expression as a result
of pharmacological inhibition or indirect activation of TGF-β are largely consistent with previ-
ous evidence from Kon et al [19], showing that intraperitoneal injection of TGF-β towards the
end of the night caused a 3 hour advance in rhythmic Per1 expression in the kidney and adre-
nal gland. In the current study only TGF-B inhibition seemed to cause a delay in the phase of
Per1b rhythmic expression, while indirect activation did not affect the phase, but caused period
shortening, which is usually associated with phase advance. These difference might be since
our manipulation, namely the addition of a TGF-β inhibitor or indirect activator to the zebra-
fish water, is inherently different from the manipulation performed by Kon et al., in the length
of the treatment (chronic vs. acute).
Pharmacological inhibition of TGF-β affected not only the molecular circadian clock, but
also clock-controlled behavior, as TGF-β inhibition disrupted the clock-controlled rhythms of
locomotor activity of larvae. This effect was evident under constant lighting conditions as well
as under LDim cycles, which failed to mask the effect of the inhibitor. General locomotor abil-
ity was not affected, as indicated by the response to dark flashes. Furthermore, the period
lengthening and phase delay in the rhythmic activity of inhibitor-treated larvae closely resem-
ble the period lengthening and phase delay in the activity of the Per1b promotor in vitro.
Therefore, we conclude that the effect of TGF-β inhibition on clock-controlled behavior can
be explained by its effect on components of the molecular circadian clock. In this regard, it will
be interesting to test whether TGF-β inhibition influences other circadian controlled behav-
iors, such as temporal feeding patterns [36]. In the future, a complementary approach of
computational modelling may be valuable to further elucidate the mechanism linking the cir-
cadian clock and TGF-β signaling. Computational modelling of regulatory networks has
proven highly valuable in analyzing and understanding system level phenomena [37–39]. Net-
work models of a discrete nature are one type of computational model that usually do not
require detailed quantitative biological data. Software tools that implement computational
models can be used to simulate network behavior and allow extensive in silico exploration of
the network performance under numerous simulated conditions. Such a tool called BioNSi
(Biological Network Simulator) was recently used to simulate the molecular mechanism of the
vertebrate circadian clock, including its bidirectional interactions with the TGF-β signaling
pathway [40]. Such a software tool will also be extremely useful to study the interactions
between the molecular circadian clock and the TGF-β signaling in zebrafish, in order to iden-
tify plausible underlying mechanisms and make new predictions that can then be tested
experimentally.
The interactions between the circadian clock and TGF-β signaling are especially intriguing
considering their possible influence on outputs of both systems. The circadian expression pat-
tern of Smad3 can control the timing of Smad2/3:Smad4 dependent transcription, and thus
cause circadian oscillations in Smad-controlled genes. On the other hand, the influence of
Smad2/3:Smad4 on Per1 and perhaps on additional clock genes affects the circadian molecular
oscillator, in turn potentially influencing the expression of CCGs. These bi-directional interac-
tions may lead to many interesting effects. For example, outputs that are usually known to be
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regulated by the circadian clock may be found to be also regulated by TGF-β, and vice versa.
In addition, these two systems may also exhibit shared complex effects, such as opposite, addi-
tive or synergistic effects. This is especially interesting since shared outputs of TGF-β signaling
and the circadian clock include the cell cycle and apoptosis, and common outcomes upon dis-
ruption of these two interconnected systems include tumorigenesis and tumor progression.
Materials and methods
1. Transcriptome data mining
Transcriptome data mining was performed on three previous transcriptome analysis experi-
ments which were performed on whole zebrafish larvae [23], adult zebrafish brains [24], and
adult zebrafish pineal glands [26].
2. Fish maintenance
Adult zebrafish were raised in a recirculation water system at the zebrafish facility of Tel Aviv
University under 12hr light:12hr dark (LD) cycles at 28˚C and fed twice each day. To generate
embryos, male and female zebrafish were paired in the evening, and spawning occurred the
next day within one hour after lights on. Embryos were placed in 10 cm petri dishes with egg
water containing methylene blue (0.3 p.p.m) and raised under LD cycles at 28˚C. For whole
mount ISH, pigmentation was prevented by adding phenylthiourea (PTU) to the embryos
water during the first two days of development. For locomotor activity analysis, embryos were
transferred into 48 plates (one larva per well) during the fourth day of development and placed
into the DanioVision observation chamber (Noldus Information Technology, the Nether-
lands). All procedures were approved by the Tel Aviv University Animal Care Committee and
conducted in accordance with the Council for Experiments on Animal Subjects, Ministry of
Health.
3. Whole mount ISH
Samples were collected at 4 hr intervals throughout the 24 hr cycle during the 6th day of devel-
opment, fixed for 24 hours in 4% paraformaldehyde and stored in 100% methanol at -20˚C.
Exposure to the TGF-β inhibitor LY-364947 at a concentration of 20μM began on the evening
of the 5th day of development. Transcripts of Smad3a, Smad3b and Per1b mRNA were detected
by whole mount ISH using digoxygenin-labelled antisense ribo-probes (DIG RNA labelling
kit, Roche Diagnostics Ltd, Basel, Switzerland). Probes were produced as previously described
and whole mount ISH analyses were carried out according to an established protocol [41].
Whole mount ISH signals in the larva head, expressed as optical density, were quantified using
ImageJ software (National Institute of Health, Bethesda, MD, USA). The larva head area was
chosen because of the higher expression of the studied genes in this region as compared to the
trunk. Differences in signal intensities between treatments and sampling times were deter-
mined by two-way ANOVA. Specific comparison within each treatment were performed
using one-way ANOVA followed by Tukey’s post-hoc test. Results are written as mean optical
density ± standard error.
4. TGF-β inhibitors and indirect activator
Pharmacological inhibition of TGF-β signaling was carried out using a selective ATP-competi-
tive inhibitor of TGF-β type-1 activin receptor-like kinase (ALK-5) , LY-364947 (L6293,
Sigma, MO), or a selective inhibitor of both ALK-4 and ALK-5, SB-431542 (S4317, Sigma,
MO). Both inhibitors were previously demonstrated to inhibit TGF-β-Smad3 mediated
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signaling in zebrafish larvae [30]. For in vitro experiments, the inhibitors were dissolved in
DMSO and added at working concentrations of 1, 5, 10 and 20 μM to the cell culture medium,
30 minutes before lights on. For in vivo experiments, LY-364947 was dissolved in DMSO and
was added to the larvae water during the evening of the 5th day of development, before lights
off, at a final concentration of 20μM.
The LY-364947 concentrations used in current experiments are higher than reported IC50
values in cell-free binding assays, which are about 0.04–0.1 μM for the target of interest,
TGFβRI [42,43]. Similar IC50 values have also been reported in several previous cell-line
based experiments [43–45]. However, multiple studies have used much higher concentrations
of LY-364947 in cell-cultures, ranging from 5μM [46] and 10μM [47] to as high as 40μM [48].
LY-364947 has not been previously used with zebrafish PAC-2 cells, but has been widely used
with zebrafish embryos, consistently at working concentrations of 30–100μM [30,49–53].
Thus, concentrations that are higher than the IC50 have been routinely used to disrupt TGF- β
signaling in cell and animal models. Accordingly, concentrations of 1–20 μM were used in the
current study, consistent with the most commonly used concentrations in previous studies
using the zebrafish model.
Pharmacological induction of TGF-β signaling was carried out using Alantolactone
(SML0415, Sigma, MO), a sesquiterpene lactone which disrupts the Cripto-1/ActRII com-
plexes, resulting in an indirect induction of activin/Smad3 signaling [31].
5. Cell cultures, constructs and real-time bioluminescence assays
The zebrafish PAC-2 cell line stably expressing per1b::luc [54] were cultured and entrained to
LD cycles as described elsewhere [55,56]. 70 hours after entrainment, stably transfected cells
were exposed to various concentrations of the TGF-β inhibitors LY-36494 or SB-431542, or
the TGF-β indirect TGF- β inducer, Alantolacton. Control groups were treated with DMSO.
Real-time bioluminescence assays were performed and analyzed as described previously
[55,56], using an EnVision multilabel counter (Perkin Elmer).
The periods of luciferase rhythms while the cells were in DD conditions were computed by
the Lomb-Scargle periodogram (α = 0.05) with Actogram software [57], and statistical differ-
ences between treated and control cells were determined by one-way ANOVA, followed by
Tukey’s post-hoc test. Amplitude values were calculated as the difference between the peak
during the first constant dark (DD) cycle after exposure and the following trough, divided by
2, and the statistical differences between treated and control larvae were determined by one-
way ANOVA, followed by Tukey’s post-hoc test. Phase values were calculated as the CT in
which luciferase activity reached its peak during the first DD cycle after exposure has occurred,
and the statistical differences between treated and control larvae were determined by one-way
ANOVA, followed by Tukey’s post-hoc test.
6. Locomotor activity monitoring of zebrafish larvae
For locomotor activity monitoring, Larvae were kept under LD conditions for three days as
previously described [26], and on the 4th day of development they were transferred into
48-well plates (one larva/well) and placed into a DanioVision observation chamber. The inhib-
itor, or DMSO, were added to the water near the end of the light phase of the 5th day of devel-
opment, approximately 30 minutes before lights-off, and larvae were then exposed to 12 hr
light (3,400 lux): 12 hr dim light (40 lux) (LDim) cycles for 3 days, or to constant dim light, a
condition in which larvae exhibit high amplitude clock-controlled rhythmic locomotor activity
[58]. Live video tracking and analysis was conducted using the Ethovision 8.0 software (Noldus
Information Technology). Activity was measured at 6–7 days post fertilization under DimDim
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or 6–8 days post fertilization under LDim, as the distance moved by a larva in 10 min time
bins. The data is presented as a moving average (10 sliding points) for each group (n = 24/
group).
For the "wash out" experiment, in which inhibitor was administered and then removed, lar-
vae were kept under LD cycles, the inhibitor was added to the larvae water during the 5th day
of development. Starting on the 6th day of development larvae were kept under DimDim for
60 hours. On the morning of the 8th day of development the inhibitor was removed by wash-
ing, replaced with fresh water, and larvae were transferred into a 48 plate and placed into the
DanioVision observation chamber. The larvae were re-entrained for 2 LDim cycles, and then
kept under constant conditions (DimDim) for 24 hours, while locomotor activity (total dis-
tance moved by one larva during a 10 min time window) was measured using the Ethovision
8.0 software. The data is presented as a moving average (10 sliding points) for each group
(n = 24/group).
Fourier analysis was used to test differences in rhythmic locomotor activity using a previ-
ously described procedure [26,28,33,58]. The time-dependent signal was converted into a fre-
quency dependent signal using the Fast Fourier Transform (FFT). The extent to which the
original signal of each larva is circadian was quantified by the ratio (‘g-factor’) of the power of
the frequency that corresponds to the 24 hr period to the sum of powers of all frequencies. The
higher the g-factor, the higher is the confidence that the larvae exhibit circadian locomotor
activity. Differences in the g-factor distributions between the control and TGF-β inhibitor
treated groups were determined by the Kolmogorov-Smirnov test. The periods of locomotor
activity rhythms were computed by the Lomb-Scargle periodogram (α = 0.05) with Actogram
software [57], and statistical differences between inhibitor treated and control larvae were
determined by t-test. Amplitude values were calculated as the difference between the second
recorded peak in activity and the preceding trough, divided by 2, and the statistical differences
between inhibitor treated and control larvae were determined by t-test. Phase values were cal-
culated as the difference between the CT of the second recorded peak of activity, and the statis-
tical differences between inhibitor treated and control larvae were determined by one-way
ANOVA.
For the “dark flash stimuli” experiment, used to observe larva mobility, larvae were placed
in DanioVision during the 5th day of development and exposed to one LD cycle. During early
light phase on the 6th day of development, the fish were subjected to 3 dark flashes of 10 sec-
onds each, with 15 minutes of light interval between flashes. The data represents the average of
three successive trials, which measured the average movement per second of each larvae,
recorded 10 seconds before the flash, during the flash and 10 seconds after the dark flash.
Supporting information
S1 Fig. Smad3b mRNA does not show circadian expression in zebrafish larvae heads.
Smad3b mRNA does not exhibit a circadian expression pattern in zebrafish larvae heads or
other tissues. (A) Top panel: schematic representation of the experimental design. The hori-
zontal bars represent the lighting conditions before and during sampling; white boxes repre-
sent light and black boxes represent dark periods. Bottom panel: Whole-mount ISH signals for
Smad3b mRNA (dorsal views of the heads) of representative specimens raised under LD cycles
until and during the sampling (LD group), or raised in DD during the sampling. Circadian
times are indicated for each sample. CT0 corresponds to "subjective lights on", CT12 to "sub-
jective lights-off". White bars represent light phases and black bars represent dark phases. (B)
Quantification of signal intensities in the head of LD and DD larvae (n = 15/group). Values
represent the mean ± SE optical densities of the head signals. White bars represent subjective
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day and black bars represent subjective night.
(TIF)
S2 Fig. The molecular circadian oscillator in PAC-2 cells is significantly altered by TGF-β
inhibition by SB-505124. Rhythmic Per1b promotor activity in the zebrafish PAC-2 cell line
was significantly altered by the addition of the TGF-β inhibitor SB-505124 in a dose-depen-
dent manner in comparison to DMSO treated control (n = 8/group). Upper panel: biolumines-
cence is plotted on the y-axis and time (hours) on the x-axis. The horizontal bars represent the
lighting conditions before and during sampling; white boxes represent light periods and black
boxes represent dark periods. Lower panel: effects of inhibition on length, phase, and ampli-
tude of Per1b promotor activity. Different letters represent statistically different values within
each parameter (p<0.05, one-way ANOVA, Tukey’s test). Treatment led to a significant
lengthening of the period of Per1b promotor activity (23.76±0, 24.2±05, 24.2±0.05, 25.24±0.16
hr for 1, 5, 10 and 20 μM, respectively, compared to 24.35±0.12 for the DMSO-treated), and
reduction in the amplitude (1313.75.25±9.37, 1128±24.02, 903±20.26, 594.19±23.29 CPS for 1,
5, 10 and 20 μM, respectively, compared to 2136.25±57.29 for the DMSO-treated control), but
not to a significant phase delay (the time of the first peak after the cells were transferred to DD
was at CT 3.74±0.12, 4.025±0.05, 3.92±1.5, 4.17±0.19 hr for 1, 5, 10 and 20 μM, respectively,
compared to 3.85±0.07 for the DMSO-treated control).
(TIF)
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